Fennec Pharmaceuticals Inc (FENC)
9.16
+0.09
(+0.99%)
USD |
NASDAQ |
Apr 25, 16:00
9.17
+0.01
(+0.11%)
After-Hours: 20:00
Fennec Pharmaceuticals Shareholders Equity (Quarterly): -11.62M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -11.62M |
September 30, 2023 | -10.53M |
June 30, 2023 | -9.727M |
March 31, 2023 | -7.339M |
December 31, 2022 | -2.569M |
September 30, 2022 | 2.802M |
June 30, 2022 | 8.541M |
March 31, 2022 | 12.52M |
December 31, 2021 | 15.77M |
September 30, 2021 | 19.01M |
June 30, 2021 | 22.28M |
March 31, 2021 | 24.93M |
December 31, 2020 | 29.07M |
September 30, 2020 | 31.18M |
June 30, 2020 | 36.13M |
March 31, 2020 | 8.461M |
December 31, 2019 | 11.88M |
September 30, 2019 | 15.00M |
June 30, 2019 | 16.48M |
March 31, 2019 | 19.21M |
December 31, 2018 | 21.31M |
September 30, 2018 | 22.86M |
June 30, 2018 | 24.86M |
March 31, 2018 | 25.66M |
December 31, 2017 | 26.76M |
Date | Value |
---|---|
September 30, 2017 | 8.858M |
June 30, 2017 | 9.679M |
March 31, 2017 | 2.861M |
December 31, 2016 | 3.57M |
September 30, 2016 | 4.22M |
June 30, 2016 | 4.653M |
March 31, 2016 | 0.243M |
December 31, 2015 | 0.548M |
September 30, 2015 | 1.019M |
June 30, 2015 | 1.112M |
March 31, 2015 | 0.826M |
December 31, 2014 | 0.613M |
September 30, 2014 | -3.228M |
June 30, 2014 | -4.658M |
March 31, 2014 | -4.334M |
December 31, 2013 | -1.455M |
September 30, 2013 | -4.127M |
June 30, 2013 | -2.429M |
March 31, 2013 | -9.065M |
December 31, 2012 | -4.957M |
September 30, 2012 | 1.284M |
June 30, 2012 | 2.045M |
March 31, 2012 | 2.595M |
December 31, 2011 | -0.12M |
September 30, 2011 | -3.67M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.62M
Minimum
Dec 2023
36.13M
Maximum
Jun 2020
11.17M
Average
12.52M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Pfizer Inc | 89.01B |
OptiNose Inc | -86.61M |
NovaBay Pharmaceuticals Inc | 3.314M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 26.86M |
Total Liabilities (Quarterly) | 38.49M |
Debt to Equity Ratio | -2.661 |
Current Ratio | 3.556 |
Net Debt Paydown Yield | -0.41% |